<DOC>
	<DOCNO>NCT02047032</DOCNO>
	<brief_summary>A noninferiority randomize controlled trial aim compare effect safety electroacupuncture versus pelvic floor muscle training ( PFMT ) plus solifenacin mixed urinary incontinence ( MUI ) .</brief_summary>
	<brief_title>Effect Electroacupuncture Versus PFMT Plus Solifenacin Mixed Urinary Incontinence</brief_title>
	<detailed_description>Participants experience mixed urinary incontinence recruit 10 center . A gynecologist urologist make diagnosis . Central randomization perform Clinical Evaluation Center China Academy Chinese Medical Sciences Beijing . Sample size : Sample size base primary outcome . According literature , investigator predict MUI patient 's average 72-h incontinence episode frequency week 1-12 decrease 60 % baseline treatment PFMT plus solifenacin . The number acupuncture group 57 % . For assessment noninferiority , 250 participant need group allow 15 % dropout ( α=0.05，β=0.2，δ=15 % ) . Quality control : A 3-level monitoring system ( monitor responsible one center , monitor responsible center monitor responsible whole trial ) establish check performance trial time . Outcome assessment , completion case report form data management strict supervision . Data management : The Remote Dara Capture ( RDC ) system use data enter . Both paper electronic case report form reserve . A data verification plan make .</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<mesh_term>Cholinergic Antagonists</mesh_term>
	<criteria>female meet meet diagnostic criterion mixed urinary incontinence age 3575 year moderate severe urinary incontinence urinary incontinence severity index 3 9 suffering urinary incontinence least 3 month 72h incontinence episode frequency≥2 baseline assessment voluntarily join research sign inform consent pure stress urinary incontinence , pure urgency urinary incontinence , overflow incontinence neurogenic bladder medicine use urinary incontinence may affect bladder function , take nondrug therapy ( electric stimulation , bladder training pelvic floor muscle training ) last month symptomatic urinary tract infection nonfunctional urologic disease ever undergone operation urinary incontinence pelvic floor ( include hysterectomy ) pelvic organ prolapse degree ≥2 residual urinary volume ( RUV ) &gt; 30 mL maximum flow rate ( Qmax ) &lt; 20 mL/s ; allergic solifenacin contradiction muscarine antagonist ( urinary retention , gastric retention , myasthenia gravis , ulcerative colitis angle closure glaucoma ) diseases affect function lower urinary tract , uncontrolled diabetes , multiple sclerosis , Alzheimer 's disease , Parkinson 's disease , spinal injury , cauda equina injury multiple system atrophy . serious cardiovascular , pulmonary , cerebral , liver , kidney , hematopoietic system psychiatric disease cognitive impairment patient severe renal dysfunction moderate hepatic dysfunction use strong Cyp3a4 Inhibitor like ketoconazole unable limited walking , stairs run poor compliance electroacupuncture , pelvic floor muscle train drug pregnancy , lactation within 12 month birth cardiac pacemaker , metal allergy , severe needle phobia . volunteer trial</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>electroacupuncture</keyword>
	<keyword>urinary incontinence</keyword>
	<keyword>PFMT</keyword>
	<keyword>Solifenacin</keyword>
</DOC>